PPP1R14B and posterior cortical atrophy: In summary, our study first proposed that PPP1R14B was a biomarker for evaluating immune characteristics, proliferation and migration in PCa, and had a close relationship with development and prognosis of PCa, which would provide useful insights and a theoretical basis for creating personalized and accurate treatment strategies and drug decisions for patients with PCa.